Fibroblast growth factor 23 and anemia in the Chronic Renal Insufficiency Cohort Study
Clinical Journal of the American Society of Nephrology Nov 14, 2017
Mehta R, et al. - This study was carried out to assess elevated fibroblast growth factor 23 as a risk factor for the development of anemia in patients with CKD. Findings demonstrated the association of elevated fibroblast growth factor 23 with prevalent anemia, change in hemoglobin over time, and development of anemia in this group of patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
